If you look at the $150K Viradx sold between 01/10/2023 and 06/12/2023 when we had a mid quarterly sales update, we has sold $150K of product. That's $16,666 per week in product sales.
If you then take the $50,000 extra reported in the quarterly between 6th December and 31st December, the same weekly sales apply.
They have maintained $16,666 per week in Viradx sales for the quarter.
So you could assume without any further uptake, they should show around $200,000 in quarterly sales for this next quarterly in product.
Add in Febridx.
Febridx for the year previous year sold around $300,000 of product.
If no further uptake (appears unlikely this wouldn't happen) then i would guess product sales for the quarter could be around
$275,000 to $325,000 total.
Anything more would show some reasonable uptake of product sales.
$16,666 of viradx sales would come to around 40 odd boxes a week in sales.
Add to My Watchlist
What is My Watchlist?
